ACIP Recommends PCV15 for Children Younger Than 19 Years
THURSDAY, Sept. 15, 2022 -- The 15-valent pneumococcal conjugate vaccine (PCV15) can be used for children aged younger than 19 years, according to recommendations issued by the Advisory Committee on Immunization Practices and published in the Sept.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 15, 2022 Category: Pharmaceuticals Source Type: news
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022
This report describes the 2022 recommendation from the Advisory Committee On Immunization Practices on use of the 15-Valent Pneumococcal Conjugate Vaccine among children. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - September 15, 2022 Category: American Health Tags: Adolescent Health Advisory Committee on Immunization Practices (ACIP) Children's Health MMWR Morbidity & Mortality Weekly Report Vaccination Vaccines Pneumococcal Disease Source Type: news
Africa: UN Health Agency Launches Roadmap for Meningitis Vaccination Campaigns
[UN News] With the COVID-19 pandemic delaying meningitis vaccination campaigns for more than 50 million children in Africa, the region is at a heightened risk of outbreaks of meningitis type A, the UN health agency said on Thursday. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 9, 2022 Category: African Health Source Type: news
Africa: Covid Threatening Resurgence of Deadly Meningitis in Africa
[VOA] Geneva -- The World Health Organization is warning of a resurgence of deadly meningitis in Africa because COVID-19 has disrupted lifesaving vaccination campaigns. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 9, 2022 Category: African Health Source Type: news
BE's pediatric pneumonia jab gets CDSCO expert panel approval
The BE's pneumococcal conjugate vaccine (PCV) can be administered to infants at 6, 10 and 14 weeks of age. Streptococcus pneumoniae infection continues to be a leading cause of child mortality under 5 years of age in India and in developing countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 1, 2022 Category: Pharmaceuticals Source Type: news
Students told to get up to date with vaccinations ahead of Freshers' Week
Students should get up to date with 3 vaccines: Men ACWY (meningitis), MMR (measles, mumps and rubella) and, for female students, HPV, before the start of the new term. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 26, 2022 Category: Consumer Health News Source Type: news
Serotypes Not in Vaccines Results in Pneumococcal Disease Serotypes Not in Vaccines Results in Pneumococcal Disease
Michael E. Pichichero, MD, discusses his group ' s findings examining current pneumococcal stereotypes in children.MDedge (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 24, 2022 Category: Consumer Health News Tags: Pediatrics Commentary Source Type: news
Students told to get up to date with vaccinations ahead of Freshers' Week, UKHSA (published 24th August 2022)
Students should get up to date with 3 vaccines: Men ACWY (meningitis), MMR (measles, mumps and rubella) and, for female students, HPV, before the start of the new term. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 24, 2022 Category: Consumer Health News Source Type: news
Pfizer announces positive top-line results from Phase 3 study of 20-valent pneumococcal conjugate vaccine in infants
Pfizer Inc. (NYSE:PFE) announced positive top-line results from its pivotal U.S. Phase 3 study (NCT04382326) in infants evaluating its 20-valent pneumococcal conjugate vaccine candidate (20vPnC) for the prevention of invasive pneumococcal disease (IPD) caused by the 20 Streptococcus pneumoniae (pneumococcus) serotypes contained in the vaccine for the pediatric population. (Source: World Pharma News)
Source: World Pharma News - August 15, 2022 Category: Pharmaceuticals Tags: Featured Pfizer Business and Industry Source Type: news
ACR Makes Changes to Adult, Pediatric Vaccinations Guidance ACR Makes Changes to Adult, Pediatric Vaccinations Guidance
The pneumococcal, recombinant zoster, and HPV vaccines are among those recommended for patients taking immunosuppressive medications.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - August 8, 2022 Category: Internal Medicine Tags: Rheumatology News Source Type: news
Pneumococcal Vax Slashed Deadly Sickle-Cell Complication in Kids
(MedPage Today) -- Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) a decade ago in France was associated with a significant reduction in acute chest syndrome (ACS) for children with sickle cell disease, a cohort study showed... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 3, 2022 Category: Hematology Source Type: news
What It Really Feels Like to Have Monkeypox
Since the global monkeypox outbreak began in May 2022, more than 22,000 cases have been confirmed in countries around the world. More than 5,000 of those cases have been recorded in the U.S., with many clustered in hotspots including New York and California. The virus, which often results in a blister-like rash and spreads through close contact, has so far predominantly affected men who have sex with men.
Even as cases tick up and monkeypox gains public attention, however, it can still be difficult to find information about testing, treatment, and vaccines. Many people who fear they are at risk or infected are left to seek...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Jamie Ducharme, Angela Haupt and Jeffrey Kluger Tags: Uncategorized healthscienceclimate monkeypox Source Type: news
The Virus Hunters Trying to Prevent the Next Pandemic
Nobody saw SARS-CoV-2 coming. In the early days of the pandemic, researchers were scrambling to collect samples from people who had mysteriously developed fevers, coughs, and breathing problems. Pretty soon, they realized that the disease-causing culprit was a new virus humans hadn’t seen before.
And the world, lacking a coordinated global response, was unprepared. Some countries acted quickly to develop tests for the novel coronavirus, while others with fewer resources were left behind. With a virus oblivious to national borders, and with travel between countries and continents more common than it had been in previo...
Source: TIME: Health - August 1, 2022 Category: Consumer Health News Authors: Alice Park and Video by Andrew D. Johnson Tags: Uncategorized Disease Frontiers of Medicine 2022 healthscienceclimate Source Type: news
The Best Way to Slow the Spread of Monkeypox
Only July 23rd, World Health Organization declared monkeypox a public health emergency of international concern (PHEIC). It was a contentious decision, with WHO Director General Dr. Tedros Adhanom Ghebreyesus making the final call and overruling the WHO’s Emergency Committee. The advisory committee’s disagreements mirrored debates unfolding among public officials, on social media, and in opinion pages over the last several weeks. Is monkeypox a public health emergency when it’s “just” spreading among gay and bisexual men and trans women? To what degree do cisgender men, women, and kids need to...
Source: TIME: Health - July 25, 2022 Category: Consumer Health News Authors: Céline R. Gounder Tags: Uncategorized freelance health Source Type: news
Why You ’ ll Need to Get COVID-19 Boosters Again and Again
Several highly effective vaccines were developed at an unprecedented speed to combat the COVID-19 pandemic. During the phase 3 clinical trials, mRNA vaccines had vaccine efficacy of 94–95% in preventing symptomatic infections. After the rollout, real-world evidence showed that the mRNA vaccines provided ~90% effectiveness against infection. Then came the variants. The wave after wave of new variants, with ever-increasing transmissibility and capacity to escape existing immunity, challenge the ability of vaccines to prevent infection and transmission. The effectiveness of a primary series of mRNA vaccines (two doses) ...
Source: TIME: Health - July 19, 2022 Category: Consumer Health News Authors: Akiko Iwasaki and Albert Ko Tags: Uncategorized COVID-19 freelance Source Type: news
